EUVIMEDEUVIMED entdecken
Crossref

RAS and RAF mutation status in the selection of patients for anti-EGFR therapy

Nuria Mulet-Margalef, Marta Domènech, Ramon Salazar

Colorectal Cancer · 2016

DOI: 10.2217/crc-2015-0013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Cancer, 2016. Verfasst von Nuria Mulet-Margalef und 2 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mulet-Margalef, N., Domènech, M., & Salazar, R. (2016). RAS and RAF mutation status in the selection of patients for anti-EGFR therapy. Colorectal Cancer. https://doi.org/10.2217/crc-2015-0013

Vancouver

Mulet-Margalef N, Domènech M, Salazar R. RAS and RAF mutation status in the selection of patients for anti-EGFR therapy. Colorectal Cancer. 2016. doi:10.2217/crc-2015-0013

BibTeX
@article{MuletMargalef2016,
  author = {Mulet-Margalef, Nuria and Domènech, Marta and Salazar, Ramon},
  title = {RAS and RAF mutation status in the selection of patients for anti-EGFR therapy},
  journal = {Colorectal Cancer},
  year = {2016},
  doi = {10.2217/crc-2015-0013}
}
Kostenlos starten →